Month: November 2021

Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2 Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

ELX-02 monotherapy dosed at 1.5mg/kg/day demonstrated a statistically significant 5.4mmol/L mean sweat chloride reduction, an established surrogate for restoration of...

The Global Impact Conference 2021 will present best practices in the field of sustainable development and real cases for addressing the challenges of our time

MOSCOW, Nov. 17, 2021 /PRNewswire/ -- The Global Impact Conference "Bridging the Gaps," an international case-based conference, will take place...

error: Content is protected !!